In vivo effects of diadenosine polyphosphates on rat renal microcirculation

Kidney International

Volumn 57, Issue 6, 2000, Pages 2476-2484

  Gabriëls, Gert ^a,b   Endlich, Karlhans ^a,b   Rahn, Karl Heinz ^a,b   Schlatter, Eberhard ^a,b   Steinhausen, Michael ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenosine receptors; Hemodynamics; Purinoceptors; Renal microvessels; Split hydronephrotic kidney model; Vasoactive nucleotides

Indexed keywords

ADENOSINE; DIADENOSINE POLYPHOSPHATE; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; FEMALE; HYDRONEPHROSIS; IN VIVO STUDY; KIDNEY CIRCULATION; MEASUREMENT; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0034075650     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00106.x     Document Type: Article

References (43)

1. 1. FLODGAARD H, KLENOW H: Abundant amounts of diadenosine 5′,5′-P1,P4-tetraphosphate are present and releasable but metabolically inactive, in human platelets. Biochem J 208:737-742, 1982
2. 2. LÜTHJE J, OGILVIE A: The presence of diadenosine 5′,5′-P1,P3-triphosphate (Ap3A) in human platelets. Biochem Biophys Res Commun 115:253-260, 1983
3. 3. SCHLÜTER H, OFFERS S, BRÜGGEMANN G, VAN DER GIET M, TEPEL M, NORDHOFF E, KARAS M, SPIEKER C, WITZEI H, ZIDEK W: Diadenosine phosphates and the physiological control of blood pressure. Nature 367:186-188, 1994
4. 4. CASTILLO CJ, MORO MA, DEL VALLE M, SILLERO A, GARCIA AG, SILLERO MA: Diadenosine tetraphosphate is co-released with ATP and catecholamines from bovine adrenal medulla. J Neurochem 59:723-732, 1992
5. 5. SILLERO MA, DEL VALLE M, ZAERA E, MICHELENA P, GARCIA AG, SILLERO A: Diadenosine 5′5′-P,1P,4-tetraphosphate (Ap4A) ATP, and catecholamine content in bovine adrenal medulla, chromaffin granules and chromaffin cells. Biochimie 76:404-409, 1994
6. 6. LÜTHJE J, OGILVIE A: Catabolism of Ap4A and Ap3A in whole blood: The dinucleotides are longlived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. Eur J Biochem 173:241-245, 1988
7. 7. OSSWALD H, HERMES HH, NABAKOWSKI G: Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int 22: 136-142, 1982
8. 8. SCHNERMANN J, WEIHPRECHI H, BRIGGS JP: Inhibition of tubuloglomerular feedback during adenosine; receptor blockade. Am J Physiol 258:F553-F561, 1990
9. 9. KHATTAB M, HOHAGE H, HOLLAH PE, RAHN KH, SCHLATTER E: Effects of diadenosine polyphosphates on systemic and regional hemodynamics in anaesthetized rats. Kidney Blood Press Res 21:42-49, 1998
10. 10. BUSSE R, OGILVIE A, POHL U: Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. Am J Physiol 254:H828-H832, 1988
11. 11. POHL U, OGILVIE A, LAMONTAGNE D, BUSSE R: Potent effects of AP3A and AP4A on coronary resistance and autacoid release of intact rabbit hearts. Am J Physiol 260:H1692-H1697, 1991
12. 12. TEPEL M, JANKOWSKI J, SCHLÜTER H, BACHMANN J, VAN DER GIET M, RUESS C, TERLIESNER J, ZIDEK W: Diadenosine polyphosphates' action on calcium and vessel contraction. Am J Hypertens 10:1404-1410, 1997
13. 13. RALEVIC V, HOYLE CH, BURNSTOCK G: Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J Physiol (Lond) 483:703-713, 1995
14. 14. HOHAGE H, REINHARDT E, BORUCKI U, ENCK G, SCHLÜTER H, SCHLATTER E, ZIDEK W: Effects of diadenosine polyphosphates on renal function and blood pressure in anesthetized Wistar rats. J Am Soc Nephrol 7:1216-1222, 1996
15. 15. VAN DER GIET M, KHATTAB M, BORGEI J, SCHLÜTER H, ZIDEK W: Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 120:1453-1460, 1997
16. 16. VAN DER GIET M, JANKOWSKI J, SCHLÜTER H, ZIDEK W, TEPEL M: Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors. J Hypertens 16:1939-1943, 1998
17. 17. COX BF, SMITS GJ: Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats. J Pharmacol Exp Ther 277:1492-1500, 1996
18. 18. INSCHO EW: Purinoceptor-mediated regulation of the renal microvasculature. J Auton Pharmacol 16:385-388, 1996
19. 19. INSCHO EW, MITCHELL KD, NAVAR LG: Extracellular ATP in the regulation of renal microvascular function. FASEB J 8:319-328, 1994
20. 20. INSCHO EW, COOK AK, NAVAR LG: Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am J Physiol 271:F1077-F1085, 1996
21. 21. INSCHO EW, COOK AK, MUI VY, MILLER J: Direct assessment of renal microvascular responses to P2-purinoceptor agonists. Am J Physiol 274:F718-F727, 1998
22. 22. RUMP LC, BOHMANN C, SCHWERTFEGER E, KRUMME B, VON KÜGELGEN I, SCHOLLMEYER P: Extracellular ATP in the human kidney: Mode of release and vascular effects. J Auton Pharmacol 16:371-375, 1996
23. 23. RUMP LC, OBERHAUSER V, VON KÜGELGEN I: Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms. Kidney Int 54:473-481, 1998
24. 24. STEINHAUSEN M, SNOEI H, PAREKH N, BAKER R, JOHNSON PC: Hydronephrosis: A new method to visualize vas afferens, efferens, and glomerular network. Kidney Int 23:794-806, 1983
25. 25. STEINHAUSEN M, ENDLICH K: Controversies on glomerular filtration from Ludwig to the present. Pflügers Arch 432:R73-R81, 1996
26. 26. HOFFEND J, CAVARAPE A, ENDLICH K, STEINHAUSEN M: Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol 256:F285-F292, 1993
27. 27. STEINHAUSEN M, BLUM M, FLEMING JT, HOLZ FG, PAREKH N, WIEGMAN DL: Visualization of renal autoregulation in the split hydronephrotic kidney of rats. Kidney Int 35:1151-1160, 1989
28. 1 adenosine receptor antagonist. Life Sci 40:555-561, 1987
29. 2 adenosine receptors. Life Sci 39:743-750, 1986
30. 2a-selective adenosine receptor antagonists. J Med Chem 40:4396-4405, 1997
31. 31. LAMBRECHT G, FRIEBE T, GRIMM U, WINDSCHIEF U, BUNGARDT E, HILDEBRANDT C, BÄUMERT HG, SPATZ KG, MUTSCHLER E: PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol 217:217-219, 1992
32. 32. BÜLTMANN R, TULUC F, STARKE K: On the suitability of adenosine 3′-phosphate 5′-phosphosulphate as a selective P2Y receptor antagonist in intact tissues. Eur J Pharmacol 351:209-215, 1998
33. 1 receptors. J Med Chem 41:183-190, 1998
34. 34. DAVIES G, MACALLISTER RJ, BOGLE RG, VALLACE P: Effect of diadenosine phosphates on human umbilical vessels: Novel platelet-derived vasoconstrictors Br J Pharmacol 40:170-172, 1995
35. 35. BO X, FISCHER B, MAILLARD M, JACOBSON KA, BURNSTOCK G: Comparative studies on the affinities of ATP derivatives for P2x-purinoceptors in rat urinary bladder. Br J Pharmacol 112:1151-1159, 1994
36. 36. INSCHO EW, OHISHI K, NAVAR LG: Effects of ATP on pre-and postglomerular juxtamedullary microvasculature. Am J Physiol 263:F886-F893, 1992
37. 37. HOLZ FG, STEINHAUSEN M: Renovascular effects of adenosine receptor agonists. Renal Physiol 10:272-282, 1987
38. 38. SUMIYOSHI R, NlSHIMURA J, KAWASAKI J, KOBAYASHI S, TAKAHASHI S, KANAIDE H: Diadenosine polyphosphates directly relax porcine coronary smooth muscle. J Pharmacol Exp Ther 283:548-556, 1997
39. 39. LÜTHJE J, OGILVIE A: Catabolism of Ap4A and AP3a in human serum: Identification of isoenzymes and their partial characterization. Eur J Biochem 169:385-388, 1987
40. 2 purinergic receptors. J Pharmacol Exp Ther 265:334-338, 1993
41. 2 purinoceptors in the rat isolated perfused kidney. Pflügers Arch 306:139-153, 1996
42. 2+ concentration in endothelial cells. Cell Physiol Biochem 8:175-184, 1998
43. 43. CHAN CM, UNWIN RJ, BARDINI M, OGLESBY IB, FORD APDW, TOWNSEND-NICHOLSON A, BURNSTOCK G: Localisation of the P2X1 purinoceptors by autoradiography and immunohistochemistry in the rat kidney. Am J Physiol 274:F799-F804, 1998